Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $10.06 ($201K) on 2022-06-21, disclosed to the SEC on 2022-06-22.
Open-market sale of $201k CTKB by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |